Abiopharma

🔍 Stilwell Joseph (Director)

Company: Wheeler Real Estate Investment Trust, Inc. (WHLR)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 1,218.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 118.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 245.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 2.00 | Footnotes: F4
• Sold 0 shares of Series B Convertible Preferred Stock at $14515200000.0 per share (Derivative)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 72,383.00 | transaction_form_type: 4 | Footnotes: F9, F8, F9, F9, F9, F2
• Sold 0 shares of Series B Convertible Preferred Stock at $14515200000.0 per share (Derivative)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 90,565.00 | transaction_form_type: 4 | Footnotes: F9, F8, F9, F9, F9, F3
• Holds 6,192,249 shares of 7.00% Subordinated Convertible Notes due 2031 at $2.77 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2031-12-31 | Footnotes: F5, F5, F5, F1
• Holds 903,974 shares of 7.00% Subordinated Convertible Notes due 2031 at $2.77 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2031-12-31 | Footnotes: F5, F5, F5, F2
• Holds 289,322 shares of 7.00% Subordinated Convertible Notes due 2031 at $2.77 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2031-12-31 | Footnotes: F5, F5, F5, F3
• Holds 424,885 shares of 7.00% Subordinated Convertible Notes due 2031 at $2.77 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2031-12-31 | Footnotes: F5, F5, F5, F4
• Holds 0 shares of Series D Cumulative Convertible Preferred Stock at $6154444800.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 108,954.00 | Footnotes: F7, F7, F7, F7, F1
• Holds 0 shares of Series D Cumulative Convertible Preferred Stock at $6154444800.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 15,798.00 | Footnotes: F7, F7, F7, F7, F2
• Holds 0 shares of Series D Cumulative Convertible Preferred Stock at $6154444800.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 19,099.00 | Footnotes: F7, F7, F7, F7, F3
• Holds 0 shares of Series D Cumulative Convertible Preferred Stock at $6154444800.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 2,289.00 | Footnotes: F7, F7, F7, F7, F4
• Holds 0 shares of Series B Convertible Preferred Stock at $14515200000.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 547,518.00 | Footnotes: F9, F9, F9, F9, F1

Footnotes:

• F1: These securities are owned directly by Stilwell Activist Investments, L.P. ("SAI") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Stilwell Value LLC ("Value"), which is the general partner of SAI. Joseph Stilwell disclaims beneficial ownership of all securities reported as owned indirectly except to the extent of his pecuniary interest therein.
• F2: These securities are owned directly by Stilwell Activist Fund, L.P. ("SAF") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SAF. Joseph Stilwell disclaims beneficial ownership of all securities reported as owned indirectly except to the extent of his pecuniary interest therein.
• F3: These securities are owned directly by Stilwell Value Partners VII, L.P. ("SVP VII") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SVP VII. Joseph Stilwell disclaims beneficial ownership of all securities reported as owned indirectly except to the extent of his pecuniary interest therein.
• F4: These securities are owned directly by Stilwell Associates, L.P. ("SA") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SA. Joseph Stilwell disclaims beneficial ownership of all securities reported as owned indirectly except to the extent of his pecuniary interest therein.
• F5: The Issuer's 7.00% Subordinated Convertible Notes due 2031 (the "Notes") are convertible, in whole or in part, at any time, at the option of the holders thereof, into shares of the Issuer's common stock at a conversion price of $2.771041 per share (9.021881 common shares for each $25.00 of principal amount of the Notes being converted).
• F6: Interest on the Notes may be payable, at the Issuer's election, in cash, in shares of the Issuer's Series B Convertible Preferred Stock ("Series B Preferred Stock") or in shares of the Issuer's Series D Cumulative Convertible Preferred Stock ("Series D Preferred Stock"), in each case as set forth in the Notes. The number of shares of the Issuer's common stock indicated in the Table is based on the outstanding principal amount of the Notes held by the Reporting Person.
• F7: Each share of Series D Preferred Stock is convertible, in whole or in part, at any time, at the option of the holders thereof, into 0.000000004 shares of the Issuer's common stock (a conversion price of $6,154,444,800 per share of common stock). Series D Preferred Stock has no expiration date.
• F8: This Form 4 reports the following sales of Series B Preferred Stock on June 26, 2026: (i) SAF sold 11,105 shares at $8.6423 per share, and (ii) SVP VII sold 13,895 shares at $8.6423 per share.
• F9: Each share of Series B Preferred Stock is convertible, in whole or in part, at any time, at the option of the holders thereof, into 0.000000002 shares of the Issuer's common stock (a conversion price of $14,515,200,000 per share of common stock). Series B Preferred Stock has no expiration date.